标题
Graft versus Leukemia in 2023
作者
关键词
-
出版物
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume -, Issue -, Pages 101476
出版商
Elsevier BV
发表日期
2023-06-11
DOI
10.1016/j.beha.2023.101476
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Three FDA-approved therapies for chronic GVHD
- (2022) Robert Zeiser et al. BLOOD
- Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants
- (2022) Eugenio Galli et al. BONE MARROW TRANSPLANTATION
- The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML
- (2022) Avichai Shimoni et al. BONE MARROW TRANSPLANTATION
- Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
- (2022) Chenchen Zhao et al. Journal of Hematology & Oncology
- Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel
- (2022) Hartmut Döhner et al. BLOOD
- Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients
- (2022) Tomoyasu Jo et al. CYTOTHERAPY
- MRD Tailored Therapy in AML: What We Have Learned So Far
- (2021) Lok Lam Ngai et al. Frontiers in Oncology
- The immunopeptidome guides permissive HLA mismatch
- (2021) Juliane Sarah Walz BLOOD
- Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia
- (2021) Antonio Pierini et al. Blood Advances
- “Ex‐vivo” T‐cell depletion in allogeneic hematopoietic stem cell transplantation for hematological malignancies: New clinical approaches for old challenges
- (2021) Miguel A. Diaz et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Non-classical manifestations of acute GVHD
- (2021) Robert Zeiser et al. BLOOD
- Regulatory T Cells in GVHD Therapy
- (2021) Wen-wen Guo et al. Frontiers in Immunology
- Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
- (2021) Takahide Ara et al. Frontiers in Immunology
- Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients
- (2021) Léa Dubreuil et al. Cancers
- Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant
- (2021) Monzr M. Al Malki et al. Blood Advances
- Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning
- (2021) Shannon R. McCurdy et al. BLOOD
- 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
- (2021) Michael Heuser et al. BLOOD
- Umbilical Cord Blood Transplantation: Still Growing and Improving
- (2021) Xiaoyu Zhu et al. Stem Cells Translational Medicine
- Updates in chronic graft-versus-host disease
- (2021) Betty K. Hamilton Hematology-American Society of Hematology Education Program
- Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
- (2020) Matthew Mankarious et al. Frontiers in Immunology
- Natural killer cells in cancer biology and therapy
- (2020) Song-Yang Wu et al. Molecular Cancer
- Minor Histocompatibility Antigen-Specific T Cells
- (2020) Corinne Summers et al. Frontiers in Pediatrics
- Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant
- (2020) Prashant Sharma et al. Blood Advances
- Lower GVHD and relapse risk in PTCy-based Haploidentical vs Matched Sibling Donor RIC Transplant for Hodgkin Lymphoma
- (2019) Sairah Ahmed et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
- (2019) Lucas P. Wachsmuth et al. JOURNAL OF CLINICAL INVESTIGATION
- MRD in AML: The Role of New Techniques
- (2019) Maria Teresa Voso et al. Frontiers in Oncology
- Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
- (2019) Christopher S. Hourigan et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients
- (2019) Jochen Greiner et al. Journal of Clinical Medicine
- Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation
- (2018) Maximilian Gröger et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Chronic graft-versus-host disease: current management paradigm and future perspectives
- (2018) Hani Mawardi et al. ORAL DISEASES
- Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
- (2018) Vito Pistoia et al. Frontiers in Immunology
- Development of Grade II Acute Graft-Versus-Host Disease is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide
- (2018) Shannon R. McCurdy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
- (2017) Asad Bashey et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
- (2017) Bart L. Scott et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
- (2017) Robert J. Soiffer et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of GvHD and Other HSCT-Related Major Complications
- (2017) Sakhila Ghimire et al. Frontiers in Immunology
- How important is NK alloreactivity and KIR in allogeneic transplantation?
- (2016) Brian C. Shaffer et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Exploitation of natural killer cells for the treatment of acute leukemia
- (2016) Rupert Handgretinger et al. BLOOD
- Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML
- (2016) C-C Zheng et al. BONE MARROW TRANSPLANTATION
- Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
- (2015) Aleksandar Radujkovic et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
- (2014) B. Gyurkocza et al. BLOOD
- HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion
- (2013) S. Stevanovi et al. BLOOD
- "Designed" grafts for HLA-haploidentical stem cell transplantation
- (2013) M. F. Martelli et al. BLOOD
- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
- (2013) C. Cutler et al. BLOOD
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease
- (2012) H. Tsukamoto et al. BLOOD
- Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial
- (2012) Martin Bornhäuser et al. LANCET ONCOLOGY
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
- (2011) R. J. Soiffer et al. BLOOD
- Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
- (2010) V. Gupta et al. BLOOD
- Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
- (2009) Yvette L. Kasamon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT
- (2009) Y Chalandon et al. BONE MARROW TRANSPLANTATION
- Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications
- (2009) Colleen Delaney et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cord blood banking: ‘providing cord blood banking for a nation’
- (2009) Sergio Querol et al. BRITISH JOURNAL OF HAEMATOLOGY
- Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
- (2009) Xuyu Zhou et al. NATURE IMMUNOLOGY
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation